Uni-Bio Science Launches Best-in-Class Oral Anti-Diabetic Drug Mitiglinide Branded “博康泰®”(Bokangtai)
- Written by Reporters
- Strengthens Position as Expert in Diabetes Management
- Steps up Preparation for Commercial Launch of Uni-E4
HONG KONG, CHINA - Media OutReach - 4 May 2017 - Uni-Bio Science Group Limited ("Uni-Bio Science" or the "Group"; HKSE: 690) today announced that, with the exclusive global rights to manufacture and commercialize Mitiglinide acquired...

